Articles
Troponin
ProBNP, BNP and NT-proBNP
Fatty Acid Binding Protein (FABP)
Myoglobin
GAPDH
C-Reactive Protein (CRP)
Lectin-Like Oxidized LDL Receptor (LOX-1)
Thyroid Peroxidase (TPO)
Pregnancy Associated Plasma Protein A (PAPP-A)
Adiponectin
Myeloperoxidase (MPO)
Retinol Binding Protein 4 (RBP4)
Influenza
Respiratory Syncytial Virus
Serum Amyloid A (SAA)
Soluble CD40 Ligand (sCD40L)
Cystatin C
Soluble Transferrin Receptor
Hepatitis B Suface antigen (HBsAg)
Human Serum Albumin (HSA)
Procalcitonin (PCT)
D-Dimer and High Molecular Weight Fibrin Degradation Products
Insulin, Proinsulin, C-peptide
Thrombin Activatable Fibrinolysis Inhibitor (TAFI)
Fibrinogen
Fibrinopeptide A
Leptin
Immunoglobulins
Urotensin II
Human Leukocyte Markers
Gangliosides
Beta-Galactosidase of E. coli
Zhu J, et al. (2011) Simultaneous Detection of High-Sensitivity Cardiac Troponin I and Myoglobin by Modified Sandwich Lateral Flow Immunoassay: Proof of Principle. Clin Chem 57, 1732-1738. doi: 10.1373/clinchem.2011.171694.
Moreno-Gonzalez A, et al. (2009) Cell therapy enhances function of remote non-infarcted myocardium. J Mol Cell Cardiol 47, 603–613.
Pettersson K, et al. (2009) Autoantibodies to Cardiac Troponin Associate with Higher Initial Concentrations and Longer Release of Troponin I in Acute Coronary Syndrome Patients. Clin Chem 55, 938-945. doi:10.1373/clinchem.2008.115469.
van den Berg G, et al. (2009) A Caudal Proliferating Growth Center Contributes to Both Poles of the Forming Heart Tube. Circ Res 104,179-188. doi:10.1161/CIRCRESAHA.108.185843.
Cho I-H, et al. (2009) Characterization for Binding Complex Formation with Site-Directly Immobilized Antibodies Enhancing Detection Capability of Cardiac Troponin I. J Biomed Biotechnol, Article ID 10409. doi:10.1155/2009/104094.
Wu AHB, et al. (2009) Specificity of a High-Sensitivity Cardiac Troponin I Assay Using Single-Molecule–Counting Technology. Clin Chem 55, 196-198. doi:10.1373/clinchem.2008.108837.
Cacchio A, et al. (2009) Response of Bone Turnover Biochemical Markers to Extracorporeal Shock Wave Therapy in the Management of Long-Bone Nonunions. Clin Chem 55, 195-196. doi: 10.1373/clinchem.2008.106419.
Aanhaanen WTJ, et al. (2009) The Tbx2+ primary myocardium of the atrioventricular canal forms the atrioventricular node and the base of the left ventricle. Circ Res 104, 1235-1237. doi: 10.1161/CIRCRESAHA.108.192450.
Panteghini M, et al. (2008) IFCC Working Group on Standardization of Troponin I.Standardization of troponin I measurements: an update. Clin Chem Lab Med 46(11),1501-1506.
Grauss RW, et al. (2008) Forced Myocardin Expression Enhances the Therapeutic Effect of Human Mesenchymal Stem Cells After Transplantation in Ischemic Mouse Hearts. Stem Cells 26(4), 1083–1093. doi: 10.1634/stemcells.2007-0523.
Hessel MHM, et al. (2008) Release of cardiac troponin I from viable cardiomyocytes is mediated by integrin stimulation. Pflugers Arch 455, 979–986.
doi: 10.1007/s00424-007-0354-8.
Sancho Solis R, et al. (2008) Single amino acid sequence polymorphisms in rat cardiac troponin revealed by top–down tandem mass spectrometry. J Muscle Res Cell Motil 29, 203–212. doi: 10.1007/s10974-009-9168-y.
Lai ZH, et al. (2008) Overexpression of TNNI3K, a cardiac-specific MAP kinase, promotes P19CL6-derived cardiac myogenesis and prevents myocardial infarction-induced injury. Am J Physiol Heart Circ Physiol 295,708-716, doi:10.1152/ajpheart.00252.2008.0363-6135/08.
Michielshen E. (2008) Implications of Cardiac Troponin T Degredation. Thesis.
HidaN, et al. (2008) Novel Cardiac Precursor-Like Cells from Human Menstrual Blood-Derived Mesenchymal Cells. Stem Cells 26(7), 1695–1704. doi: 10.1634/stemcells.2007-0826.
Hildreth V, et al. (2008) Cells migrating from the neural crest contribute to the innervation of the venous pole of the heart. J Anat 212(1), 1–11. doi: 10.1111/j.1469-7580.2007.00833.x
Schultze AE, et al. (2008) Ultrasensitive Cross-species Measurement of Cardiac Troponin-I Using the Erenna Immunoassay System. Toxicol Pathol 36(6), 777-782.
doi: 10.1177/0192623308322016.
Urasawa N, et al. (2008) Selective Vacuolar Degeneration in Dystrophin-Deficient Canine Purkinje Fibers Despite Preservation of Dystrophin-Associated Proteins With Overexpression of Dp71. Circulation 117, 2437-2448.
doi: 10.1161/CIRCULATIONAHA.107.739326.
Bakker ML, et al. (2008) Transcription factor Tbx3 is required for the specification of the atrioventricular conduction system. Circ Res 102, 1295-1297.
doi: 10.1161/CIRCRESAHA.107.169565.
NishiyamaN, et al. ( 2007) The Significant Cardiomyogenic Potential of Human Umbilical Cord Blood-Derived Mesenchymal Stem Cells In Vitro. Stem Cells 25(8), 2017–2024. doi: 10.1634/stemcells.2006-0662.
Mommersteeg MTM, et al. (2007) Molecular Pathway for the Localized Formation of the Sinoatrial Node. Circ Res100,354-362. doi: 10.1161/01.RES.0000258019.74591.b3.
Winter M, et al. (2007) Preservation of left ventricular function and attenuation of remodeling after transplantation of human epicardium-derived cells into the infarcted mouse heart. Circulation August 7. doi: 10.1161/CIRCULATIONAHA.106.668178.
Du CK, et al. (2007) Knock-in mouse model of dilated cardiomyopathy caused by troponin mutation. Circ Res 101, 185-194. doi: 10.1161/CIRCRESAHA.106.146670.
Soufan AT, et al. (2007) Three-dimensional measurement and visualization of morphogenesis applied to cardiac embryology. J Microsc 225(3), 269–274.
Grauss RW, et al. (2007) Mesenchymal stem cells from ischemic heart disease patients improve left ventricular function after acute myocardial infarction. Am J Physiol Heart Circ Physiol 293, 2438-2447. doi:10.1152/ajpheart.00365.2007.0363-6135/07.
Cobbaert C, et al. (2007) Do NIST SRM 2921 and recombinant cTnI-based serum pools have potential to harmonize cTnI results? Ned Tijdschr Klin Chem Labgeneesk 32(3), 175-178.
Todd J, et al. (2007) Ultrasensitive Flow-based Immunoassays Using Single-Molecule Counting. Clin Chem53, 1990-1995. doi: 10.1373/clinchem.2007.091181
Willis MS, et al. (2007) Bovine cardiac troponin T is not accurately quantified with a common human clinical immunoassay. J Vet Diagn Invest 19(1), 106-108.
Cazorla O, et al. (2006) Length and protein kinase A modulations of myocytes in cardiac myosin binding protein C-deficient mice. Cardiovasc Res 69 (2): 370-380.
doi: 10.1016/j.cardiores.2005.11.009.
Ylikotila J, et al. (2006) Utilization of recombinant Fab fragments in a cTnI immunoassay conducted in spot wells. Clin Biochem 39 (8), 843-850.
Bunk DM and Welch MJ (2006) Characterization of a New Certified Reference Material for Human Cardiac Troponin I. Clin Chem 52, 212-219. doi: 10.1373/clinchem.2005.051359.
O'Brien PJ, et al. (2006) Cardiac troponin I is a sensitive, specific biomarker of cardiac injury in laboratory animals. Lab Anim 40, 153-171. doi:10.1258/002367706776319042.
Christenson RH, et al. (2006) Toward Standardization of Cardiac Troponin I Measurements Part II: Assessing Commutability of Candidate Reference Materials and Harmonization of Cardiac Troponin I Assays. Clin Chem 52, 1685-1692. doi: 10.1373/clinchem.2006.068437.
Madsen LH, et al. (2006) Time course of degradation of cardiac troponin I in patients with acute ST-elevation myocardial infarction: the ASSENT-2 troponin substudy. Circ Res 99, 1141-1147. doi:10.1161/01.RES.0000249531.23654.e1.
Michielsen E, et al. (2006) Interpretation of cardiac troponin T behaviour in size-exclusion chromatography. Clin Chem Lab Med 44(12),1422–1427. doi: 10.1515/CCLM.2006.265.
El-Armouche A, et al. (2006) Molecular Determinants of Altered Ca2+ Handling in Human Chronic Atrial Fibrillation. Circulation 114, 670-680.
doi: 10.1161/CIRCULATIONAHA.106.636845.
Ilva T, et al. (2005) Improved early risk stratification and diagnosis of MI, using a novel TnI assay concept. Eur J Clin Invest 35(2), 112-116. doi: 10.1111/j.1365-2362.2005.01466.x.
Eriksson S, et al. (2005) Comparison of Cardiac Troponin I Immunoassays Variably Affected by Circulating Autoantibodies. Clin Chem 51, 848-855. doi: 10.1373/clinchem.2004.040089.
Eriksson S, et al. (2005) Negative Interference in Cardiac Troponin I Immunoassays by Circulating Troponin Autoantibodies. Clin Chem 51, 839-847.
doi: 10.1373/clinchem.2004.040063.
Szilágyi S. (2005) Molecular determinants of myofibrillar contractile function in the heart. Dissertation.
Goncalves MAVF, et al. (2005) Transfer of the full-length dystrophin-coding sequence into muscle cells by a dual high-capacity hybrid viral vector with site-specific integration ability. J Virol 79(5) 3146-3162. doi:10.1128/JVI.79.5.3146-3162.2005.
Fraser CG, et al. (2005) Quality specifications for imprecision of B-type natriuretic peptide assays. Clin Chem 51, 1307-1309. doi: 10.1373/clinchem.2005.050393
Feng X, et al. (2005) Limited additional release of cardiac troponin I and T in isoproterenol-treated beagle dogs with cardiac injury. Clin Chem 51, 1305-1307.
doi: 10.1373/clinchem.2005.049643.
Eriksson S, et al. (2004) An interfering component in cardiac troponin I immunoassays. Clin Biochemistry 37(6), 472-480.
Cazorla O, et al. (2004) Transmural stretch-dependent regulation of contractile properties in rat heart and its alteration after myocardial infarction. FASEB J 19, 88-90. doi:10.1096/fj.04-2066fje.
Pamminger T, et al. (2004) Decreased protein and phosphorylation level of the protein phosphatase inhibitor-1 in failing human hearts. Cardiovasc Res 61 (1), 87-93. doi:10.1016/j.cardiores.2003.11.005.
Pagani F, et al. (2004) Innotrac aio! Second-generation cardiac troponin I assay: imprecision profile and other key characteristics for clinical use. Clin Chem 50, 1271-1272.
doi:10.1373/clinchem.2004.033258.
Eriksson S, et al. (2004) The Interfering Component in Cardiac Troponin I Immunoassays. Clin Chem 50, 1101-1102. doi:10.1373/clinchem.2004.034454.
Rafat M, et al. (2004) Apolipoprotein A-IV in the fed and fasting states. Clin Chem 50, 1270-1271. doi: 10.1373/clinchem.2004.033001.
Marston SB and Redwood CS (2003) Modulation of thin fi lament activation by breakdown or isoform witching of thin fi lament Proteins. Circ Res 93: 1170-1178. doi:10.1161/01.RES.0000105088.06696.17
Katrukha AG. (2003) Antibody selection strategies in cardiac troponin assays. Cardiac Markers, 2nd edition, Edited by Alan HB. Wu. 173-185.
Deng Y, et al. (2003) Phosphorylation of human cardiac troponin I G203S and K206Q linked to familial hypertrophic cardiomyopathy affects actomyosin interaction in different ways. J Mol Cell Cardiol 35(11), 1365-1374.
Fukuhara S, et al. (2003) Direct cell-cell interaction of cardiomyocytes is key for bone marrow stromal cells to go into cardiac lineage in vitro. J Thorac Cardiovasc Surg 125, 1470-1480.
Eriksson S, et al. (2003) Negative interference in cardiac troponin I immunoassays from a frequently occurring serum and plasma component. Clin Chem 49, 1095-1104.
doi: 10.1373/49.7.1095.
Sarko J and Pollack CV Jr. (2002) Cardiac troponins. J Emerg Med 23(1), 57-65.
Goette A, et al. (2002) Calpains and cytokines in fibrillating human atria. Am J Physiol Heart Circ Physiol 283, 264-272. doi:10.1152/ajpheart.00505.20010363-6135/02.
Uettwiller-Geiger D, et al. (2002) Multicenter Evaluation of an Automated Assay for Troponin I Denise Uettwiller-Geiger. Clin Chem 48, 869-876.
Hamm CW. (2001) Acute coronary syndromes. The diagnostic role of troponins. Thromb Res 103(1), 63-69.
Onuoha GN, et al. (2001) Skeletal troponin-I release in orthopedic and soft tissue injuries. J Orthop Sci 6(1), 11-15.
Christenson RH, et al. (2001) Standardization of Cardiac Troponin I Assays: Round Robin of Ten Candidate Reference Materials. Clin Chem 47, 431-437.
Hammerer-Lercher A, et al. (2001) Clinical and Experimental Results on Cardiac Troponin Expression in Duchenne Muscular Dystrophy. Clin Chem 47, 451-458.
Labugger R, et al. (2000) Extensive troponin I and T modification detected in serum from patients with acute myocardial infarction. Circulation. 102(11), 1221-1226.
Bertinchant JP, et al. (2000) Comparison of the diagnostic value of cardiac troponin I and T determinations for detecting early myocardial damage and the relationship with histological findings after isoprenaline induced cardiac injury in rats. Clin Chim Acta 298(1- 2), 13-28.
Katrukha A, et al.1999) Biochemical factors influencing measurement of cardiac troponin I in serum. Clin Chem Lab Med 37(11-12), 1091-1095.
Katrukha A, et al. (1999) New approach to standardisation of human cardiac troponin I (cTnI). Scand. J Clin Lab Invest Suppl 230, 124-7.
Filatov VL, et al. (1999) Troponin: structure, properties, and mechanism of functioning. Biochemistry (Mosc) 64(9), 969-985.
Wilson DH et al. (1999) Antibody selection for the Abbott AxSYM troponin I assay. Clin Chem 45, 2293-2294.
Nakaura H, et al. (1999) Functional changes in troponin T by a splice donor site mutation that causes hypertrophic cardiomyopathy. Am J Physiol Cell Physiol 27, 225-232.
Giuliani I, et al. (1999) Determination of Cardiac Troponin I Forms in the Blood of Patients with Acute Myocardial Infarction and Patients Receiving Crystalloid or Cold Blood Cardioplegia. Clin Chem 45, 213-222.
Reiffert SU, et al. (1998) Stepwise subunit interaction changes by mono- and bisphosphorylation of cardiac troponin I. Biochemistry 37(39), 13516-13525.
Katrukha AG, et al. (1998) Degradation of cardiac troponin I: implication for reliable immunodetection. Clin Chem 44(12), 2433-2440.
Filatov VL, et al. (1998) Epitope mapping of anti-troponin I monoclonal antibodies. Biochem Mol Biol Int 45(6), 1179-1187.
Ferrieres G, et al. (1998) Human cardiac troponin I: precise identification of antigenic epitopes and prediction of secondary structure. Clin Chem44, 487-493.
Wu AHB, et al. (1998) Characterization of cardiac troponin subunit release into serum after acute myocardial infarction and comparison of assays for troponin T and I. Clin Chem 44, 1198-1208.
Katrukha AG, et al.(1997) Troponin I is released in bloodstream of patients with acute myocardial infarction not in free form but as complex. Clin Chem 43(8), 1379-1385.
Jaquet K, et al. (1995) Pattern formation on cardiac troponin I by consecutive phosphorylation and dephosphorylation. Eur J Biochem 231(2), 486-490.
Katrukha AG, et al. (1995) A new method of human cardiac troponin I and troponin T purification. Biochem Mol Biol Int 36(1), 195-202.
Katrukha AG, et al. (1993) Isolation of human cardiac troponin T and localization of epitopes recognized by monoclonal antibodies to cardiac troponin T. FEBS Letters 315(1), 25-28.
Katus HA, et al. (1989) Enzyme linked immunoassay of cardiac troponin T for the detection of acute myocardial infarction in patients. J Mol Cell Cardiol. 21(12), 1349-1353.
Cummins B, et al. (1987) Cardiac-specific troponin-I radioimmunoassay in the diagnosis of acute myocardial infarction. Am Heart J 113(6), 1333-1344.
ProBNP, BNP and NT-proBNP to the top
Semenov AG and Seferian KR (2011) Biochemistry of the human B-type natriuretic peptide precursor and molecular aspects of its processing. Clin Chim Acta 412(11-12), 850-860. doi:10.1016/j.cca.2011.03.006
Tamm NN, et al. (2011) Measurement of B-type natriuretic peptide by two assays utilizing antibodies with different epitope specificity. Clin Biochem 44(2-3), 257-259. doi:10.1016/j.clinbiochem.2010.09.030
Semenov AG, et al. (2010) Processing of Pro-B-Type Natriuretic Peptide: Furin and Corin as Candidate Convertases. Clin Chem 56(7).
doi: 10.1373/clinchem.2010.143883
Semenov AG, et al. (2009) Processing of pro-brain natriuretic peptide is suppressed by O-glycosylation in the region close to the cleavage site. Clin Chem 55(3), 489-498. doi: 10.1373/clinchem.2008.113373
Tamm NN, et al. (2008) Novel immunoassay for quantification of brain natriuretic peptide and its precursor in human blood. Clin Chem 54(9), 1511-8. doi: 10.1373/clinchem.2007.100545
Seferian KR, et al. (2008) Immunodetection of glycosylated NT-proBNP circulating in human blood. Clin Chem 54(5), 866-73.
doi: 10.1373/clinchem.2007.100040
LuckenbillKN, et al. (2008) Cross-Reactivity of BNP, NT-proBNP, and proBNP in Commercial BNP and NT-proBNP Assays: Preliminary Observations from the IFCC Committee for Standardization of Markers of Cardiac Damage. Clin Chem 54, 619-621.
doi: 10.1373/clinchem.2007.097998
Waldo SW, et al. (2008) Pro-B-Type Natriuretic Peptide Levels in Acute Decompensated Heart Failure. J Am Coll Cardiol 51, 1874-1882. doi:10.1016/j.jacc.2007.12.051.
Crimmins DL and Kao JLH (2008) A glycosylated form of the human cardiac hormone pro B-type natriuretic peptide is an intrinsically unstructured monomeric protein. Arch Biochem Biophys 475(1), 36–41. doi:10.1016/j.abb.2008.04.007
Hammerer-Lercher A, et al. (2008) Analysis of circulating forms of proBNP and NT-proBNP in patients with severe heart failure. Clin Chem 54, 858-865. doi: 10.1373/clinchem.2007.090266.
Heublein MD, et al. (2007) Immunoreactivity and Guanosine 3',5'-Cyclic Monophosphate Activating Actions of Various Molecular Forms of Human B-Type Natriuretic Peptide. Hypertension 49, 1114-1119. doi:10.1161/HYPERTENSIONAHA.106.081083.
Seferian KR,et al. (2007) The brain natriuretic peptide (BNP) precursor is the major immunoreactive form of BNP in patients with heart failure. Clin Chem 53, 866-873. doi: 10.1373/clinchem.2006.076141
Giuliani I, et al. (2006) Assay for Measurement of Intact B-Type Natriuretic Peptide Prohormone in Blood. Clin Chem 52, 1054-1061. doi: 10.1373/clinchem.2005.061770.
Masson S, et al. (2006) Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data. Clin Chem 52, 1528-38. doi: 10.1373/clinchem.2006.069575
Schellenberger U, et al. (2006) The precursor to B-type natriuretic peptide is an O-linked glycoprotein. Arch Biochem Biophys 451(2), 160-166. doi:10.1016/j.abb.2006.03.028
Mueller T, et al. (2005) Diagnostic accuracy of B type natriuretic peptide and amino terminal proBNP in the emergency diagnosis of heart failure. Heart 91(5), 606-612. doi:10.1136/hrt.2004.037762
Pandey KN, (2005) Biology of natriuretic peptides and their receptors. Peptides 26(6), 901-932. doi:10.1016/J.peptides.2004.09.024
Hess G, et al. (2005) N-terminal pro-brain natriuretic peptide (NT-proBNP) in healthy blood donors and in patients from general practitioners with and without a diagnosis of cardiac disease. Clin Lab 51(3-4), 167- 172.
Heeschen C, et al. (2004) N-terminal pro-B-type natriuretic peptide levels for dynamic risk stratification of patients with acute coronary syndromes. Circulation 110(20), 3206-3212.
doi: 10.1161/01.CIR.0000147611.92021.2B
Wu AH,et al. (2004) Analytical and clinical evaluation of the Bayer ADVIA Centaur automated B-type natriuretic peptide assay in patients with heart failure: a multisite study. Clin Chem 50, 867-873. doi: 10.1373/clinchem.2003.026138
Ala-Kopsala M, et al. (2004) Molecular heterogeneity has a major impact on the measurement of circulating N-terminal fragments of A- and B-type natriuretic peptides. Clin Chem 50,1576-1588. doi: 10.1373/clinchem.2004.032490
Cowie MR and Mendez GF, (2002) BNP and congestive heart failure. Prog Cardiovasc Dis 44(4), 293-321. doi: 10.1053/pcad.2002.24599
Mair J, at al. (2001) The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure. Clin Chem Lab Med 39(7), 571-88. doi: 10.1515/CCLM.2001.093
Troughton RW, et al. (2000) Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. Lancet 355, (9210), 1126-1130.
Fatty Acid Binding Protein (FABP) to the top
Claudia Dellas , et al. (2010) Elevated Heart-Type Fatty Acid-Binding Protein Levels on Admission Predict an Adverse Outcome in Normotensive Patients With Acute Pulmonary Embolism. J Am Coll Cardiol 55(19), 2150-2157.
Akbal E, et al. (2009) Serum heart type fatty acid binding protein levels in metabolic syndrome. Endocrine 36(3), 433-437, doi: 10.1007/s12020-009-9243-6
Oktay B,et al. (2008) Evaluation of the relationship between heart type fatty acid binding protein levels and the risk of cardiac damage in patients with obstructive sleep apnea syndrome. Sleep Breath 12(3), 223-228.
Azzazy HM, et al. (2006) Unbound free fatty acids and heart-type fatty acid-binding protein; diagnostic assays and clinical applications. Clin Chem 52, 19-29. doi: 10.1373/clinchem.2005.056143
Lescuyer P, et al. (2005) Heart-fatty acid-binding protein as a marker for early detection of acute myocardial infarction and stroke. Mol Diagn 9(1), 1-7.
Alhadi HA and Fox KA, (2004) Do we need additional markers of myocyte necrosis: the potential value of heart fatty-acid binding protein. QJ Med 97, 187–198.doi: 10.1093/qjmed/hch037
Wu A, (2003) Cardiac markers. 2nd edition. Humana Press
Petzold T, et al. (2001) Heart-type fatty acid binding protein (hFABP) in the diagnosis of myocardial damage in coronary artery bypass grafting. Eur J Cardiothorac Surg 19(6), 859-864.
Storch J and Thumser AE, (2000) The fatty acid transport function of fatty acid-binding proteins. Biochim Biophys Acta 1486, 28–44.
Fransen EJ, et al. (1998) Demonstration of ischemia-reperfusion injury separate from postoperative infarction in coronary artery bypass graft patients. Ann Thorac Surg 65(1),48-53.
Zhang F, et al. (1997) Solution structure of human intestinal fatty acid binding protein: implications for ligand entry and exit. J Biomol NMR 9(3), 213-228.
Wodzig KW, et al. (1997) Estimation of myocardial infarct size from plasma myoglobin or fatty acid-binding protein.Influence of renal function. Eur J Clin Chem Clin Biochem 35(3),191-198.
Ishii J, et al. (1997) Early detection of successful coronary reperfusion based on serum concentration of human heart type cytoplasmic fatty acid-binding protein. Clin Chim Acta 262(1-2),13-27.
Myoglobin to the top
Penttila K. et al. (2002) Myoglobin, creatine kinase MB isoforms and creatine kinase MB mass in early diagnosis of myocardial infarction in patients with acute chest pain. Clin Biochem 35(8), 647-653.
Srinivas VS. et al. (2001) Myoglobin levels at 12 hours identify patients at low risk for 30-day mortality after thrombolysis in acute myocardial infarction: a Thrombolysis in Myocardial Infarction 10B substudy. Am Heart J 142(1), 29-36.
doi: 10.1067/mhj.2001.116068
Van Nieuwenhoven FA, et al. (1995) Discrimination between myocardial and skeletal muscle injury by assessment of the plasma ratio of myoglobin over fatty acid-binding protein. Circulation 92(10), 2848-2854.
Kagen L, et al. (1977) Serum myoglobin in myocardial infarction: the “staccato phenomenon.” Is acute myocardial infarction in man an intermittent event? Am J Med 62(1), 86-92.
GAPDH to the top
Sin W-C, et al. (2009) Regulation of Early Neurite Morphogenesis by the Na+/H+ Exchanger NHE1. J Neurosci 29(28), 8946-8959.
doi: 10.1523/JNEUROSCI.2030-09.2009.
Immenschuh S, et al. (2009) Transcriptional induction of junctional adhesion molecule-C gene expression in activated T cells. J Leukoc Biol 85, 796-803. doi:10.1189/jlb.0708422.
Naidu S, et al. (2009) Inhibition and Genetic Deficiency of p38 MAPK Up-Regulates Heme Oxygenase-1 Gene Expression via Nrf2. J Immunol 182, 7048 -7057. doi: 10.4049/jimmunol.0900006.
Lenk K, et al. (2009) Impact of exercise training on myostatin expression in the myocardium and skeletal muscle in a chronic heart failure model.
doi: 10.1093/eurjhf/hfp020.
Antsiferova M,. et al. (2009) Keratinocyte-derived follistatin regulates epidermal homeostasis and wound repair. Lab Invest 89, 131–141. doi:10.1038/labinvest.2008.120.
Zolk O, et al. (2009) Functional Characterization of the Human Organic Cation Transporter 2 Variant p.270Ala>Ser. DMD 37(6), 1312-1318.
doi: 10.1124/dmd.108.023762.
Samalecos A, et al. (2009) Characterization of a novel telomerase-immortalized human endometrial stromal cell line, St-T 1 b. Reprod Biol Endocrinol 7, 76. doi:10.1186/1477-7827-7-76.
Branney PA, et al. (2009) Characterisation of the fibroblast growth factor dependent transcriptome in early development. PLoS ONE 4(3), 4951.
doi: 10.1371/journal.pone.0004951.
Komi Y, et al. (2009) Mechanism of inhibition of tumor angiogenesis by β-hydroxyisovalerylshikonin. Cancer Sci 100(2) 269–277.
doi: 10.1111/j.1349-7006.2008.01049.x.
Pereira JA, et al. (2009) Integrin-linked kinase is required for radial sorting of axons and Schwann cell remyelination in the peripheral nervous system. J Cell Biol 185(1), 147-161. doi: 10.1083/jcb.200809008.
Konjer N. (2009) The role of the transcription factor SRF in the inhibition of senescence in human and porcine smooth muscle cells. Thesis.
Ishida Y, et al. (2009) Autophagic Elimination of Misfolded Procollagen Aggregates in the Endoplasmic Reticulum as a Means of Cell Protection. Mol Biol Cell 20(11), 2744–2754.
doi: 10.1091/mbc.E08-11-1092
Wagner KM, et al. (2009) Targeting and Function of the Mitochondrial Fission Factor GDAP1 Are Dependent on Its Tail-Anchor. PLoS ONE 4(4), e5160. doi: 10.1371/journal.pone.0005160
Iwamaru Y, et al. (2008) Lactoferrin induces cell surface retention of prion protein and inhibits prion accumulation. J Neurochem 107(3), 636–646. doi: 10.1111/j.1471-4159.2008.05628.x.
Naletova I, et al. (2008) Non-native glyceraldehyde-3-phosphate dehydrogenase can be an intrinsic component of amyloid structures. Biochim Biophys Acta 1784(12), 2052-2058.
Naletova I, et al. (2008) Non-native glyceraldehyde-3-phosphate dehydrogenase can be an intrinsic component of amyloid structures. Biochim Biophys Acta 1784(12), 2052-2058.
Boengler K, et al. (2008) Cardioprotection by Ischemic Postconditioning Is Lost in Aged and STAT3-Deficient Mice. Circ Res 102, 131-135. doi:10.1161/CIRCRESAHA.107.164699.
Weck MM, et al. (2008) hDectin-1 is involved in uptake and cross-presentation of cellular antigens. Blood 111(8), 4264-4272. doi: 10.1182/blood-2006-10-051375.
Naidu S, et al. (2008) An Atypical NF-kB-Regulated Pathway Mediates Phorbol Ester-Dependent Heme Oxygenase-1 Gene Activation in Monocytes. J Immunol 181, 4113 -4123.
Matsumoto Y, et al. (2008) Reduced number and function of endothelial progenitor cells in patients with aortic valve stenosis: a novel concept for valvular endothelial cell repair. Eur Heart J 30(3), 346-355, doi: 10.1093/eurheartj/ehn501.
Hirayama S, et al. (2008) MKKS is a centrosome-shuttling protein degraded by disease-causing mutations via CHIP-mediated ubiquitination. Mol Biol Cell 19(3), 899-911. doi: 10.1091/mbc.E07-07-0631.
Hipp MM, et al. (2008) Sorafenib, but not sunitinib, affects function of dendritic cells and induction of primary immune responses. Blood 111(12), 5610-5620. doi: 10.1182/blood-2007-02-075945.
Heinzel FR, et al. (2008) Inducible nitric oxide synthase expression and cardiomyocyte dysfunction during sustained moderate ischemia in pigs. Circ Res 103(10), 1120-1127.
doi: 10.1161/CIRCRESAHA.108.186015.
Naidu S (2008) Signaling Pathways and Transcriptional Regulation of Antioxidant Genes Peroxiredoxin I and Heme Oxygenase-1 Gene activation in RAW264. 7 Monocytes. Thesis.
Holleben M, et al. (2008) Functional Characterisation of SLy2 as a novel regulator of the actin cytoskeleton. Thesis.
Chen Y, et al. (2008) Wnt signaling is required for organization of the lens fiber cell cytoskeleton and development of lens three-dimensional architecture. Dev Biol 324(1), 161–176.
doi: 10.1016/j.ydbio.2008.09.002.
Jessberger S, et al. 2008) Cdk5 Regulates Accurate Maturation of Newborn Granule Cells in the Adult Hippocampus. PLoS Biol 6(11), 2465-2475. doi: 10.1371/journal.pbio.0060272.
Jacob C, et al. (2008) Expression and localization of Ski determine cell type–specific TGFβ signaling effects on the cell cycle. J Cell Biol 182(3), 519–530. doi: 10.1083/jcb.200710161.
Shields S-K, et al. (2007) Rho Guanosine 5'-Triphosphatases Differentially Regulate Insulin-Like Growth Factor I (IGF-I) Receptor-Dependent and -Independent Actions of IGF-II on Human Trophoblast Migration. Endocrinology 148(10), 4906-4917. doi:10.1210/en.2007-0476.
Kueper T, et al. (2007) Vimentin Is the Specific Target in Skin Glycation. J Biol Chem 282, 23427-23436. doi: 10.1074/jbc.M701586200.
Brauer KM, et al. (2007) BCR-ABL Activity Is Critical for the Immunogenicity of Chronic Myelogenous Leukemia Cells. Cancer Res 67, 5489. doi: 10.1158/0008-5472.CAN-07-0302.
Adams V, et al. (2007) Myocardial expression of Murf-1 and MAFbx after induction of chronic heart failure: Effect on myocardial contractility. Cardiovasc Res 73 (1),120-129.
doi: 10.1016/j.cardiores.2006.10.026.
BuczynskiMW, et al. (2007) TLR-4 and Sustained Calcium Agonists Synergistically Produce Eicosanoids Independent of Protein Synthesis in RAW264.7 Cells. J Biol Chem 282, 22834-22847.
doi: 10.1074/jbc.M701831200.
Wal RM, et al. (2007) Angiotensin II type 2 receptor vasoactivity in internal mammary arteries of patients with coronary artery disease. J Cardiovasc Pharmacol 50 (4), 372-379.
doi: 10.1097/FJC.0b013e31811ea222.
Nencioni A, et al. (2007) Histone deacetylase inhibitors affect dendritic cell differentiation and immunogenicity. Clin Cancer Res 13, 3933. doi: 10.1158/1078-0432.CCR-06-2903.
Lam QLK, et al. (2007) Leptin includes CD40 expression through the activation of AKT in murine dendritic cells. J Biol Chem 282, 27587-27597. doi: 10.1074/jbc.M704579200
Danzer KM, et al. (2007) Different species of {alpha}-synuclein oligomers induce calcium influx and seeding. J Neurosci 27(34), 9220-9232. doi:10.1523/JNEUROSCI.2617-07.2007.
De Paz JL, et al. (2007) Potentiation of fibroblast growth factor activity by synthetic heparin oligosaccharide glycodendrimers. Chem Biol 14(8), 879-887. doi:10.1016/j.chembiol.2007.07.007.
Benninger Y, et al. (2007) Essential and distinct roles for cdc42 and rac1 in the regulation of Schwann cell biology during peripheral nervous system development. J Cell Biol177(6), 1051-1061.
doi: 10.1083/jcb.200610108.
Thomas M. (2007) Studying the role of the fusion protein MLL-AF4 in leukemogenesis with the help of siRNAs. Thesis.
Kurz D. (2007) Charakterisierung des Proteins P275 in dendritischen Zellen. Thesis.
Pankow S and Bamberger C (2007) The p53 Tumor Suppressor-Like Protein nvp63 Mediates Selective Germ Cell Death in the Sea Anemone Nematostella vectensis.PLoS ONE 2(9), e782.
doi: 10.1371/journal.pone.0000782.
Gellersen B, et al. (2007) Expression of the Metastasis Suppressor KAI1 in Decidual Cells at the Human Maternal-Fetal Interface : Regulation and Functional Implications. Am J Pathol 170(1), 126–139. doi: 10.2353/ajpath.2007.060175
Bentham M et al. (2006) Role of myristoylation and N-terminal basic residues in membrane association of the human immunodeficiency virus type 1 Nef protein. J Gen Virol 87, 563-71. doi: 10.1099/vir.0.81200-0
Lee DC et al. (2006) Enhanced cystatin C and lysosomal protease expression following 6-hydroxydopamine exposure. Neurotoxicology 27(2), 260-276.
Rouleau C, et al. (2006) Protein tyrosine phosphatase PRL-3 in malignant cells and endothelial cells: expression and function. Mol Cancer Ther 5(2), 219-229. doi: 10.1158/1535-7163.MCT-05-0289
Dove B et al. (2006) Cell cycle perturbations induced by infection with the coronavirus infectious bronchitis virus and their effect on virus replication. J Virol 80, 4147-4156. doi: 10.1128/JVI.80.8.4147-4156.2006
Fraser M, et al. (2006) Regulation of p53 and suppression of apoptosis by the soluble guanylyl cyclase/cGMP pathway in human ovarian cancer cells. Oncogene 25(15), 2203-2212.
doi: 10.1038/sj.onc.1209251
Carroll RC, et al. (2006) Prospective evaluation of platelet B2 bradykinin and thrombopoietin receptor levels from preeclamptic compared to non-preeclamptic pregnancy patients. Thromb Res 117(5), 551-556. doi:10.1038/sj.onc.1209251
Fediuc S, et al. (2006) Effect of voluntary wheel running on circadian corticosterone release and on HPA axis responsiveness to restraint stress in Sprague-Dawley rats. J Appl Physiol 100(6), 1867-1875. doi:10.1152/japplphysiol.01416.2005
8750-7587/06
8750-7587/06
von Wnuck Lipinski K, et al. (2006) Integrin-Mediated Transcriptional Activation of Inhibitor of Apoptosis Proteins Protects Smooth Muscle Cells Against Apoptosis Induced by Degraded Collagen. Circ Res 98,1490-1497.
doi: 10.1161/01.RES.0000229267.77982.0d.
Kitada S, et al. (2006) Cytocidal actions of parasporin-2, an anti-tumor crystal toxin from Bacillus thuringiensis. J Biol Chem281, 26350-26360. doi: 10.1074/jbc.M602589200.
Ostrakhovitcha EA, et al. (2006) Interaction of metallothionein with tumor suppressor p53 protein. FEBS Letters 580(5), 1235-1238. doi:10.1016/j.febslet.2006.01.036.
Patel AB, et al. (2006) Heat-shock protein 25 ameliorates calcium oxalate crystal-mediated oxidative stress in renal epithelial cells. BJU Int 98(5), 1094-1099. doi: 10.1111/j.1464-410X.2006.06478.x
El-Darwish KS, et al. (2006) Differential expression of members of the E2F family of transcription factors in rodent testes. Reprod Biol Endocrinol 4, 63. doi:10.1186/1477-7827-4-63.
Zhu L, et al. (2006) Changes in Tight Junctional Resistance of the Cervical Epithelium Are Associated with Modulation of Content and Phosphorylation of Occludin 65-Kilodalton and 50-Kilodalton Forms. Endocrinology 147(2), 977-989. doi:10.1210/en.2005-0916.
Lam QLK, et al. (2006) Involvement of leptin signaling in the survival and maturation of bone marrow-derived dendritic cells. Eur J Immunol 36(12), 3118–3130. doi: 10.1002/eji.200636602.
Eltzschig HK, et al. (2006) ATP release from activated neutrophils occurs via connexin 43 and modulates adenosine-dependent endothelial cell function. Circ Res 99, 1100-1108. doi: 10.1161/01.RES.0000250174.31269.70.
Krietsch T. et al. (2006) Human Homologs of the Putative G Protein-Coupled Membrane Progestin Receptors (mPRα, ß, and γ) Localize to the Endoplasmic Reticulum and Are Not Activated by Progesterone. Mol Endocrinol 20(12), 3146-3164. doi:10.1210/me.2006-0129.
Adams V, et al. (2005) Impact of Regular Physical Activity on the NAD(P)H Oxidase and Angiotensin Receptor System in Patients With Coronary Artery Disease. Circulation 111, 555-562. doi: 10.1161/01.CIR.0000154560.88933.7E.
Thomas M, et al. (2005) Targeting MLL-AF4 with short interfering RNAs inhibits clonogenicity and engraftment of t(4;11)-positive human leukemic cells. Blood 106(10), 3559-3566. doi: 10.1182/blood-2005-03-1283
Salameh A, et al. (2005) Subchronic alpha-and beta-adrenergic regulation of cardiac gap junction protein expression. FASEB J 20, 365-367. doi:10.1096/fj.05-4871fje.
Collart C, et al. (2005) The novel Smad-interacting protein Smicl regulates Chordin expression in the Xenopus embryo. Development 132, 4575-4586. doi: 10.1242/dev.02043.
Alberti S, et al. (2005) Neuronal migration in the murine rostral migratory stream requires serum response factor. Proc Natl Acad Sci102( 17), 6148-6153. doi: 10.1073/pnas.0501191102.
Boengler K, et al. (2005) Connexin 43 in cardiomyocyte mitochondria and its increase by ischemic preconditioning. Cardiovasc Res 67 (2), 234-244. doi: 10.1016/j.cardiores.2005.04.014.
Wijayanti N, et al. (2005) Heme Oxygenase-1 Gene Activation by the NAD(P)H Oxidase Inhibitor 4-(2-Aminoethyl) Benzenesulfonyl Fluoride via a Protein Kinase B, p38-dependent Signaling Pathway in Monocytes. J Biol Chem 280, 21820-21829. doi: 10.1074/jbc.M502943200.
Kessen UA, et al. (2005) PGE2 release is independent of upregulation of Group V phospholipase A2 during long-term stimulation of P388D1 cells with LPS. J Lipid Res 46, 2488-2496. doi: 10.1194/jlr.M500325-JLR200.
Krumenacker JS, et al. (2005) Effects of the JNK inhibitor anthra [1, 9-cd] pyrazol-6 (2H)-one (SP-600125) on soluble guanylyl cyclase {alpha} 1 gene regulation and cGMP synthesis. Am J Physiol Cell Physiol 289, 778-784. doi:10.1152/ajpcell.00057.2005.0363-6143/05.
Zhu L, et al. (2005) Changes in Tight Junctional Resistance of the Cervical Epithelium Are Associated with Modulation of Content and Phosphorylation of Occludin 65-Kilodalton and 50-Kilodalton Forms. Endocrinology 147(2), 977–989.
doi: 10.1210/en.2005-0916
Wetzel U, et al. (2005) Expression of connexins 40 and 43 in human left atrium in atrial fibrillation of different aetiologies. Heart 91(2), 166–170. doi: 10.1136/hrt.2003.024216.
Arden C, et al. (2004) Glucokinase is an integral component of the insulin granules in glucose-responsive insulin secretory cells and does not translocate during glucose stimulation. Diabetes 53(9), 2346-2352. doi: 10.2337/diabetes.53.9.2346.
Adams O, et al. (2004) Role of indoleamine-2, 3-dioxygenase in alpha/beta and gamma interferon-mediated antiviral effects against herpes simplex virus infections. J Virol 78(5), 2632-2636.
doi: 10.1128/JVI.78.5.2632-2636.2004.
Schag K, et al. (2004) Identification of C-met oncogene as a broadly expressed tumor-associated antigen recognized by cytotoxic T-lymphocytes. Clin Cancer Res 10, 3658. doi: 10.1158/1078-0432.CCR-03-0640.
Hucke C, et al. (2004) Nitric oxide-mediated regulation of gamma interferon-induced bacteriostasis: inhibition and degradation of human indoleamine 2, 3-dioxygenase. Infect Immun 72(5), 2723-2730. doi: 10.1128/IAI.72.5.2723-2730.2004.
Atarashi N, et al. (2004) The Absence of Prion-Like Infectivity in Mice expressing Prion Protein-Like Protein. EXCLI J 3, 82-90.
Pohnke Y, et al. (2004) Wild-type p53 protein is up-regulated upon cyclic adenosine monophosphate-induced differentiation of human endometrial stromal cells. J Clin Endocrinol Metab 89(10), 5233-5244. doi: 10.1210/jc.2004-0012
Boldt A, et al. (2004) Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease. Heart 90(4), 400–405. doi: 10.1136/hrt.2003.015347.
Hambrecht R, et al. (2003) Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase. Circulation 107, 3152-3158. doi: 10.1161/01.CIR.0000074229.93804.5C.
Mangold U, et al. (1999) Identification and characterization of potential new therapeutic targets in inflammatory and autoimmune diseases. Eur J Biochem 266(3), 1184–1191.
doi: 10.1046/j.1432-1327.1999.00978.x.
Grigorieva JA, et al. (1999) Antibodies to the nonnative forms of d-glyceraldehyde-3-phosphate dehydrogenase: identification, purification, and influence on the renaturation of the enzyme. Arch Biochem Biophys 369(2), 252-260.
Dainiak MB, et al. (1998) Conjugates of monoclonal antibodies with polyelectrolyte complexes-- an attempt to make an artificial chaperone. Biochim Biophys Acta 1381(3), 279-285. doi:10.1016/S0304-4165(98)00035-X
C-Reactive Protein (CRP) to the top
Cook JD, et al. (2005) The influence of high-altitude living on body iron. Blood 106(4), 1441-1446. doi: 10.1182/blood-2004-12-4782.
Silaste ML, et al. (2004) Changes in Dietary Fat Intake Alter Plasma Levels of Oxidized Low-Density Lipoprotein and Lipoprotein(a). Arterioscler Thromb Vasc Biol 24, 498-503. doi: 10.1161/01.ATV.0000118012.64932.f4.
Tarkkinen p, et al. (2002) Ultrarapid, Ultrasensitive One-Step Kinetic Immunoassay for C-Reactive Protein (CRP) in Whole Blood Samples: Measurement of the Entire CRP Concentration Range with a Single Sample Dilution. Clin Chem 48, 269-277.
Lectin-Like Oxidized LDL Receptor (LOX-1) to the top
Mehta J, et al. (2006) Lectin-like, oxidized low-density lipoprotein receptor-1 (LOX-1): A critical player in the development of atherosclerosis and related disorders. Cardiovasc Res 69(1), 36-45.
doi: 10.1016/j.cardiores.2005.09.006
Hayashida K, et al. (2005) Serum Soluble Lectin-Like Oxidized Low-Density Lipoprotein Receptor-1 Levels Are Elevated in Acute Coronary Syndrome: A Novel Marker for Early Diagnosis. Circulation 112, 812-818.
doi: 10.1161/CIRCULATIONAHA.104.468397
Tatsuguchi M, et al. (2003) Oxidized LDL receptor gene (OLR1) is associated with the risk of myocardial infarction. Biochem Biophys Res Commun 303(1), 247-250.
Libby P (2001) Current concepts of the pathogenesis of acute coronary events. Circulation 104, 365-372.
Sawamura T, et al. (1997) An endothelial receptor for oxidized low density lipoprotein. Nature 386, 73-77. doi: 10.1038/386073a0
Thyroid Peroxidase (TPO) to the top
Moreau V, et al. (2008) PEPOP: Computational design of immunogenic peptides. BMC Bioinformatics 9, 71. doi:10.1186/1471-2105-9-71
Bresson D, et al. (2005) New insights into the conformational dominant epitopes on thyroid peroxidase recognized by human autoantibodies. Endocrinology 146(6), 2834-2844. doi:10.1210/en.2005-0038
Bresson D, et al. (2004) Directed Mutagenesis in Region 713-720 of Human Thyroperoxidase Assigns 713KFPED717 Residues as Being Involved in the B Domain of the Discontinuous Immunodominant Region Recognized by Human Autoantibodies. J Biol Chem 279, 39058-39067.
doi: 10.1074/jbc.M403897200
Thrasyvoulides A, et al. (2004) Antibodies cross-reacting with thyroglobulin and thyroid peroxidase are induced by immunization of rabbits with an immunogenic thyroglobulin 20mer peptide. Clin Exp Immunol138(3), 423–429. doi: 10.1111/j.1365-2249.2004.02657.x
Furuya F, et al. (2004) Adenovirus-mediated transfer of thyroid transcription factor-1 induces radioiodide organification and retention in thyroid cancer cells. Endocrinology 145(11), 5397-5405. doi:10.1210/en.2004-0631
Furuya F, et al. (2004) Histone Deacetylase Inhibitors Restore Radioiodide Uptake and Retention in Poorly Differentiated and Anaplastic Thyroid Cancer Cells by Expression of the Sodium/Iodide Symporter Thyroperoxidase and Thyroglobulin. Endocrinology 145(6), 2865-2875. doi:10.1210/en.2003-1258
Bresson D, et al. (2003) Localization of the Discontinuous Immunodominant Region Recognized by Human Anti-thyroperoxidase Autoantibodies in Autoimmune Thyroid Diseases. J Biol Chem 278, 9560-9569. doi: 10.1074/jbc.M211930200
Chapal N, et al. (2001) Thyroid peroxidase autoantibodies obtained from random single chain FV libraries contain the same heavy/light chain combinations as occur in vivo. Endocrinology 142(11), 4740-4750.
Gardas A, et al. (1999)Distinct immunological and biochemical properties of thyroid peroxidase purified from human thyroid glands and recombinant protein produced in insect cells.Biochim Biophys Acta 1433 (1-2), 229-239.
Finke R, et al. (1990) Evidence for the highly conformational nature of the epitope(s) on human thyroid peroxidase that are recognized by sera from patients with Hashimoto's thyroiditis. J Clin Endocrinol Metab 71(1), 53-59.
Kendler DL, et al. (1990) Detection of autoantibodies to recombinant human thyroid peroxidase by sensitive enzyme immunoassay. Clin Endocrinol 33(6), 751-760.
Ohwovoriole AE, et al. (1989) Effectiveness of different methods to eliminate interference by thyroglobulin antibodies in the ELISA for thyroid microsomal autoantibodies.Asian Pac J Allergy Immunol 7(2), 79-83.
Doble ND, et al. (1988)Autoantibodies to the thyroid microsomal/thyroid peroxidase antigen are polyclonal and directed to several distinct antigenic sites. Immunology 64(1), 23-29.
Wietman AP, et al. (1987) Heterogeneity of thyroid autoantigens identified by immunoblotting.Clin Immunol Immunopathol 43(3), 333-342.
Czarnocka B, et al. (1985)Antigenic relation between thyroid peroxidase and the microsomal antigen implicated in auto-immune diseases of the thyroid. C R Acad Sci III 300(15), 577-580.
Mariotti S, et al, (1983) A new solid phase immunoradiometric assay for antithyroid microsomal antibody.J Clin Endocrinol Metab 56(3), 467-473.
Goodburn R, et al. (1982)The preparation of thyroid microsomal antigen for use in the indirect micro-ELISA method for the detection of anti-thyroid microsomal autoantibody. Clin Chim Acta 119(3), 291-297.
Pregnancy Associated Plasma Protein A (PAPP-A) to the top
Qin QP, et al. (2006) Immunoassays developed for pregnancy-associated plasma protein-A (PAPP-A) in pregnancy may not recognize PAPP-A in acute coronary syndromes. Clin Chem 52(3), 398-404. doi: 10.1373/clinchem.2005.058396
Heeschen C, et al. (2005) Pregnancy-associated plasma protein-A levels in patients with acute coronary syndromes Comparison with markers of systemic inflammation, platelet activation, and myocardial necrosis. J Am Coll Cardiol 45(2), 229-237. doi:10.1016/j.jacc.2004.09.060
Qin QP, et al. (2005) Molecular distinction of circulating pregnancy-associated plasma protein A in myocardial infarction and pregnancy. Clin Chem 51(1), 75-83. doi: 10.1373/clinchem.2004.036467
Wapner R, et al. (2003) First-trimester screening for trisomies 21 and 18. N Engl J Med 349, 1405-1413.
Qin OP, et al. (2002) Point-of-care time-resolved immunofluorometric assay for human pregnancy-associated plasma protein A: use in first-trimester screening for Down syndrome. Clin Chem48, 473-483.
Qin QP, et al. (2002) Release Patterns of Pregnancy Associated Plasma Protein A (PAPP-A) in Patients with Acute Coronary Syndroms. Scand Cardiovasc J 36(6), 358-361. doi: 10.1080/140174302762659085
Bayes-Genis A, et al. (2001) Pregnancy-associated plasma protein A as a marker of acute coronary syndromes. N Engl J Med 345(14), 1022-10929.
Overgaard MT, et al. (2000) Expression of recombinant human pregnancy-associated plasma protein-A and identification of the proform of eosinophil major basic protein as its physiological inhibitor. J Biol Chem 275(40), 31128-31133. doi: 10.1074/jbc.M001384200
Lawrence J, et al. (1999) The insulin-like growth factor (IGF)-dependent IGF binding protein-4 protease secreted by human fi broblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci USA 96 (6), 3149-3153.
Kristensen T, et al. (1994) Amino acid sequence of human pregnancy-associated plasma protein-A derived from cloned cDNA. Biochemistry 33(6),1592-1598.
Oxvig C, et al. (1993) Circulating human pregnancy associated plasma protein-A is disulfide-bridged to the proform of eosinophil major basic protein. J Biol Chem 268(7), 12243-12246.
Wald N, et al. (1992) First trimester concentrations of pregnancy associated plasma protein A and placental protein 14 in Down’s syndrome. BMJ 305, 28.
Adiponectin to the top
Kadowaki T, et al. (2007) Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndrome. J Clin Invest 116(7), 1784-1792. doi: 10.1172/JCI29126.
Wang Y, et al. (2006) Post-translational Modifications of the Four Conserved Lysine Residues within the Collagenous Domain of Adiponectin Are Required for the Formation of Its High Molecular Weight Oligomeric Complex. J Biol Chem 281(24), 16391-16400. doi: 10.1074/jbc.M513907200
Hara K, et al. (2006) Measurement of the High–Molecular Weight Form of Adiponectin in Plasma Is Useful for the Prediction of Insulin Resistance and Metabolic Syndrome. Diabetes Care 29(6), 1357-1362. doi: 10.2337/dc05-1801
Matsuzawa Y, et al. (2004) Adiponectin and metabolic syndrome. Arterioscler Tromb Vasc Biol 24(1), 29-33. doi: 10.1161/01.ATV.0000099786.99623.EF
Kumada M, et al. (2003) Association of hypoadiponectinemia with coronary artery disease in men. 2003. Arterioscler Thromb Vasc Biol 23, 85-89. doi: 10.1161/01.ATV.0000048856.22331.50
Myeloperoxidase (MPO) to the top
Klebanoff SJ (2005) Myeloperoxidase: friend and foe. J Leukos Biol 77, 598- 625. doi: 10.1189/jlb.1204697
Nambi V (2005) The use of myeloperoxidase as a risk marker for atherosclerosis. Curr Atheroscler Rep 7(2), 127-131.
Chevrier I, et al. (2003) Myeloperoxidase: new polymorphisms and relation with lung cancer risk. Pharmacogenetics. 13(12), 729-739.
Brennan ML, et al. (2003) Prognostic value of myeloperoxidase in patients with chest pain. New Eng J Med. 349(17), 1595-1604.
Baldus S, et al. (2003) Myeloperoxidase serum level predicts risk in patients with acute coronary syndromes. Circulation 10: 1440-1445. doi: 10.1161/01.CIR.0000090690.67322.51
Choi HK, et al. (2001) Diagnostic performance of antineutrophil cytoplasmic antibody tests for idiopathic vasculitides: meta-analysis with a focus on antimyeloperoxidase antibodies. J Rheumatol 28(7), 1584-1590.
Zhang R, et al. (2001) Association between myeloperoxidase levels and risk of coronary artery disease. JAMA 286(17), 2136-2142.
Reynolds WF, et al. (2000) MPO and APOEepsilon4 polymorphisms interact to increase risk for AD in Finnish males. Neurology 55(9), 1284-1290.
Nagra RM, et al. (1997) Immunohistochemical and genetic evidence of myeloperoxidase involvement in multiple sclerosis. J Neuroimmunol 78(1-2), 97-107.
Nauseef WM, et al. (1988) Biosynthesis and processing of myeloperoxidase – a marker for myeloid cell differentiation. Eur J Haematol 40(2), 97-110.
Retinol Binding Protein 4 (RBP4) to the top
Lewis J, et al. (2008) Plasma retinol-binding protein is unlikely to be a useful marker of insulin resistance. Diabetes Res Clin Pract 80, 13-15. doi:10.1016/j.diabres.2007.12.002
Qi Q, et al. (2007) Elevated retinol-binding protein 4 levels are associated with metabolic syndrome in Chinese people. J Clin Endocrinol Metab 92, 4827-4834. doi:10.1210/jc.2007-1219
Promintzer M, et al. (2007) Insulin resistance is unrelated to circulating retinol binding protein and protein C inhibitor. J Clin Endocrinol Metab 92, 4306-4312.doi:10.1210/jc.2006-2522
Graham T, et al. (2007) Shortcomings in methodology complicate measurements of serum retinol binding protein (RBP4) in insulin resistant human subjects. Diabetologia 50, 814-824. doi:10.1007/s00125-006-0557-0
Graham T, et al. (2006) Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. New Engl J Med 354 (24), 2552-2563.
Yang Q, et al. (2005) Serum retinol binding protein 4 contributes to insulin resistance inobesity and type 2 diabetes. Nature 436, 356-362. doi:10.1038/nature03711
Jaconi S, et al. (1995) Characterization of two post-translationally processed forms of human serum retinol-binding protein: altered ratios in chronic renal failure. J Lip Res 36, 1247-1253.
Graham T, et al. (2007) Shortcomings in methodology complicate measurements of serum retinol binding protein (RBP4) in insulin resistant human subjects. Diabetologia 50, 814-824. doi:10.1007/s00125-006-0557-0
Graham T, et al. (2006) Retinol-binding protein 4 and insulin resistance in lean, obese, and diabetic subjects. New Engl J Med 354 (24), 2552-2563.
Yang Q, et al. (2005) Serum retinol binding protein 4 contributes to insulin resistance inobesity and type 2 diabetes. Nature 436, 356-362. doi:10.1038/nature03711
Jaconi S, et al. (1995) Characterization of two post-translationally processed forms of human serum retinol-binding protein: altered ratios in chronic renal failure. J Lip Res 36, 1247-1253.
Influenza to the top
Stech O, et al. (2009)Acquisition of a Polybasic Hemagglutinin Cleavage Site by a Low-Pathogenic Avian Influenza Virus Is Not Sufficient for Immediate Transformation into a Highly Pathogenic Strain. J Virol 83(11), 5864–5868. doi: 10.1128/JVI.02649-08
Koskinen JO, et al. (2007) Rapid Method for Detection of Influenza A and B Virus Antigens by Use of a Two-Photon Excitation Assay Technique and Dry-Chemistry Reagents. J Clin Microbiol 45(11), 3581–3588. doi: 10.1128/JCM.00128-07
Unoshima M, et al. (2003) Antiviral effects of geranylgeranylacetone: enhancement of MxA expression and phosphorylation of PKR during influenza virus infection. Antimicrob Agents Chemother 47(9), 2914-2921.
doi: 10.1128/AAC.47.9.2914-2921.2003
Respiratory Syncytian Virus to the top
Huttinger C. (2009) Isolation and Characterisation of High-Affinity Peptides Directed Against Surface Glycoproteins of Pathogenic Viruses. Thesis.
Arnold R, et al. (2005) Respiratory syncytial virus infection of human lung endothelial cells enhances selectively intercellular adhesion molecule-1 expression. J Immunol 174, 7359-7367.
Serum Amyloid A (SAA) to the top
Ogasawara K, et al. (2004) A serum amyloid A and LDL complex as a new prognostic marker in stable coronary artery disease. Atherosclerosis 174(2), 349-356. doi:10.1016/j.atherosclerosis.2004.01.030
Johnson BD, et al. (2004) Serum amyloid A as a predictor of coronary artery disease and cardiovascular Outcome in women. Circulation 109, 726-732. doi: 10.1161/01.CIR.0000115516.54550.B1
Ricker PM, et al. (2000) C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med 342(12), 836-843.
Liuzzo G, et al. (1994) The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 331(7), 417-424.
Malle E, et al. (1993) Serum amyloid A (SAA): an acute phase protein and apolipoprotein. Atherosclerosis, 102: 131-146.
Marhaug G, et al. (1982) Characterization of amyloid related protein SAA compleed with serum lipoprotein (apoSAA). Clin Exp Immunol 50(2), 382-389.
Benson MD and Cohen AS (1979) Serum amyloid A protein in amyloidosis, rheumatic, and enoplastic diseases. Arthritis Rheum. 22(1), 36-42.
Soluble CD40 Ligand (sCD40L) to the top
Thor U, et al. (2005) Soluble CD40 ligand in acute and chronic heart failure. Eur Heat J 26(11), 1101-1107. doi: 10.1093/eurheartj/ehi132
Varo N, et al. (2003) Soluble CD40L: risk prediction after acute coronary syndromes. Circulation. 108(9),1049-1052.
doi: 10.1161/01.CIR.0000088521.04017.13
Garlichs CD, et al. (2001) Patients with acute coronary syndromes express enhanced CD40 ligand/CD154 on platelets. Heart 86, 649–655. doi: 10.1136/heart.86.6.649
Francois M, et al. (1998) Reduction of atherosclerosis in mice by inhibition of CD40 signalling. Nature. 394(9), 200-203.
Henn V, et al. (1998) CD40 ligand on activated platelets triggers an inflammatory reaction of endothelial cells. Nature 391(6667), 591–594.
Mach F, et al. (1997) Activation of monocyte/macrophage functions related to acute atheroma complication by ligation of CD40. Induction of collagenase, stromelysin, and tissue factor. Circulation 96, 396–399.
Gerritse K, et al. (1996) CD40-CD40 ligand interactions in experimental allergic encephalomyelitis and multiple sclerosis. Proc. Natl Acad. Sci. USA 93(6), 2499–2504.
Durie FH, et al. (1993) Prevention of collagen-induced arthritis with an antibody to gp39, the ligand for CD40. Science 261(5126), 1328–1330.
Hollenbaugh D, et al. (1992) The human T cell antigen gp39, a member of the TNF gene family, is a ligand for the CD40 receptor: expression of a soluble form of gp39 with B cell co-stimulatory activity. EMBO J 11(12), 4313–4321.
Cystatin C to the top
Lian J, et al. (2009) Altered microRNA expression in patients with non-obstructive azoospermia. Reprod Biol Endocrinol 7 (13). doi: 10.1186/1477-7827-7-13
Roos JF, et al. (2007) Diagnostic accuracy of cystatin C compared to serum creatinine for the estimation of renal dysfunction in adults and children-A meta-analysis. Clin Biochem 40(5-6), 383-391. doi:10.1016/j.clinbiochem.2006.10.026
Lassus J, et al. (2007) Prognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNP. Eur Heart J 28(15), 1841-1847. doi: 10.1093/eurheartj/ehl507
Shlipak MG, et al. (2005) Cystatin C and the risk of death and cardiovascular events among elderly persons. N Engl J Med 352(20), 2049- 2060.
Artunc FH, et al. (2005) Improved estimation of GFR by serum cystatin C in patients undergoing cardiac catheterization. Int J Cardiol 102(2), 173-178. doi: 10.1016/j.ijcard.2004.04.009
Uchida K and Gotoh A (2002) Measurement of cystatin-C and creatinine in urine. Clin Chim Acta 323(1-2), 121-128. doi:10.1016/S0009-8981(02)00177-8
Turk B, et al. (2002) Regulating Cysteine Protease Activity: Essential Role of Protease Inhibitors As Guardians and Regulators. Current pharmaceutical Design 8(18), 1623-1637.
Coll E, et al. (2000) Serum cystatin C as a new marker for noninvasive estimation of glomerular filtration rate and as a marker for early renal impairment. Am J Kidney Dis 36(1), 29-34.
Asgeirsson B, et al. (1998) Hereditary cystatin C amyloid angiopathy: monitoring the presence of the Leu-68-->Gln cystatin C variant in cerebrospinal fl uids and monocyte cultures by MS. Biochem J 329 (Pt 3), 497-503.
Schnittger S, et al. (1993) Cystatin C (CST3), the candidate gene for hereditary cystatin C amyloid angiopathy (HCCAA), and other members of the cystatin gene family are clustered on chromosome 20p11.2. Genomics 16(1), 50-55. doi:10.1006/geno.1993.1139
Soluble Transferrin Receptor to the top
Vikstedt R, et al. (2004) Rapid One-Step Immunofluorometric Assay for Measuring Soluble Transferrin Receptor in Whole Blood. Clin Chem 50, 1831-1833, doi: 10.1373/clinchem.2004.036780.
Erhardt JG, et al. (2004) Combined Measurement of Ferritin, Soluble Transferrin Receptor, Retinol Binding Protein, and C-Reactive Protein by an Inexpensive, Sensitive, and Simple Sandwich Enzyme-Linked Immunosorbent Assay Technique. Nutr Clin Pract 134, 3127-3132.
Hepatitis B Suface Antigen (HBsAg) to the top
Watanabe T, et al. (2007) Involvement of host cellular multivesicular body functions in hepatitis B virus budding. PNAS 104(24), 10205-10210. doi: 10.1073/pnas.0704000104
Wursthorn K, et al. (2006) Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B. Hepatology 44(3), 675–684. doi: 10.1002/hep.21282.
Wursthorn K, et al. (2006) Peginterferon alpha-2b plus adefovir induce strong cccDNA decline and HBsAg reduction in patients with chronic hepatitis B. Hepatology 44(3), 675–684. doi: 10.1002/hep.21282.
Huang L-R, et al. (2006) An immunocompetent mouse model for the tolerance of human chronic hepatitis B virus infection. Proc Natl Acad Sci U S A 103(47), 17862–17867.
doi: 10.1073/pnas.0608578103
Human Serum Albumin (HSA) to the top
Salmasi AM, et al. (2003) The degree of albuminuria is related to left ventricular hypertrophy in hypertensive diabetics and is associated with abnormal left ventricular filling: a pilot study. Angiology 54(6), 671-678.
doi: 10.1177/000331970305400606
Wachtell K, et al. (2003) Albuminuria and cardiovascular risk in hypertensive patients with left ventricular hypertrophy: the LIFE study. Ann Intern Med 139(11), 901-906.
Bennett PH, et al. (1995) Screening and management of microalbuminuria in patients with diabetes mellitus: recommendations to the Scientific Advisory Board of the National Kidney Foundation from an ad hoc committee of the Council on Diabetes Mellitus of the National Kidney Foundation. Am J Kidney Dis 25(1), 107-112.
Procalcitonin (PCT) to the top
Sponholz C, et al. (2006) Diagnostic value and prognostic implications of serum procalcitonin after cardiac surgery: a systematic review of the literature. Critical Care 10, R145. doi: 10.1186/cc5067
Potapov EV, et al. (2003) Elevated donor cardiac troponin T and procalcitonin indicate two independent mechanisms of early graft failure after heart transplantation. Int J Cardiol 92(2-3), 163-167.
doi: 10.1016/S0167-5273(03)00083-4
Meisner M, (2002) Pathobiochemistry and clinical use of procalcitonin. Clin Chim Acta 323, 17-29.
Meisner M and Reinhart K (2001) Is procalcitonin really a marker of sepsis? Int J Intensive Care 8(1), 15-25.
Assicot M, et al. (1993) High serum procalcitonin concentrations in patients with sepsis and infection. Lancet, 341(8844), 515-518. doi:10.1016/0140-6736(93)90277-N
Le Moullec JM, et al. (1984) The complete sequence of human procalcitonin. FEBS Letters 167(1), 93-97. doi:10.1016/0014-5793(84)80839-X
D-Dimer and High Molecular Weight Fibrin Degradation Products to the top
Bounameaux H, et al. (1994) Plasma measurement of D-dimer as diagnostic aid in suspected venous thromboembolism: an overview. Thromb Haemost 71(1), 1-6.
Rowbotham BJ, et al. (1987) Measurement of crosslinked fibrin derivatives--use in the diagnosis of venous thrombosis. Thromb Haemost 57(1), 59-61.
Rowbotham BJ, et al. (1987) Measurement of crosslinked fibrin derivatives--use in the diagnosis of venous thrombosis. Thromb Haemost 57(1), 59-61.
Insulin, Proinsulin, C-peptide to the top
Back SH, et al. (2009) Translation Attenuation through eIF2 [alpha] Phosphorylation Prevents Oxidative Stress and Maintains the Differentiated State in [beta] Cells. Cell Metabolism 10(1), 13-26. doi:10.1016/j.cmet.2009.06.002.
Kojima H, et al. (2004) Extrapancreatic insulin-producing cells in multiple organs in diabetes. Proc Natl Acad Sci101(8), 2458-2463. doi: 10.1073/pnas.0308690100.
Clark PM (1999) Assays for insulin, proinsulin(s) and C-peptide. Ann Clin Biochem 36( Pt 5), 541-564.
Rhodes CJ, et al. (1992) Preferential cleavage of des-31,32-proinsulin over intact proinsulin by the insulin secretory granule type II endopeptidase. Implication of a favored route for prohormone process ing. J Biol Chem 267(32), 22719-22727.
Davidson HW, et al. (1988) Intraorganellar calcium and pH control proinsulin cleavage in the pancreatic beta cell via two distinct site-specific endopeptidases. Nature 333(6168), 93-96.
Davidson HW and Hutton JC (1987) The insulin-secretory-granule carboxypeptidase H. Purification and demonstration of involvement in proinsulin processing. Biochem J 245(2), 575-582.
Horwitz DL, et al. (1975) Proinsulin, insulin, and C-peptide concen trations in human portal and peripheral blood. J Clin Invest 55(6), 1278-1283.
Thrombin Activatable Fibrinolysis Inhibitor (TAFI) to the top
Eichinger S, et al. (2004) Thrombin activatable fibrinolysis inhibitor (TAFI) and the risk of recurrent venous thromboembolism. Blood 103(10):3773–3776. doi: 10.1182/blood-2003-10-3422.
Lau HK, et al. (2003) Thrombin-activatable fibrinolysis inhibitor (TAFI): a novel predictor of angiographic coronary restenosis. Thromb Haemost 90(6), 1187-1191. doi: 10.1160/TH03-05-0308
Gils A, at al. (2003) Development of a genotype 325-specific proCPU/TAFI ELISA. Arterioscler Thromb Vasc Biol 23(6), 1122-1127. doi: 10.1161/01.ATV.0000074145.58172.BD
Colucci M, et al. (2003) Deficiency of thrombin activatable fibrinolysis inhibitor in cirrhosis is associated with increased plasma fibrinolysis. Hepatology 38(1), 230-7.
doi: 10.1053/jhep.2003.50277
Schroeder V, et al. (2002) Thrombin activatable fibrinolysis inhibitor (TAFI) levels in patients with coronary artery disease investigated by angiography. Thomb Haemost 88(6), 1020-1025.
Marx PF, et al. (2002) Plasmin-mediated activation and inactivation of thrombin-activatable fibrinolysis inhibitor. Biochemistry 41(21), 6688-6696.
doi: 10.1021/bi015982e
Chetaille P, et al. (2000) Plasma TAFI antigen variations in healthy subjects. Thromb Haemost 83(6), 902-905.
Van Tilburg NH, et al. (2000) Thrombin activatable fi brinolysis inhibitor and the risk for deep vein thrombosis. Blood 95(9), 2855-2959.
Silveira A, et al. (2000) Plasma procarboxypeptidase U in men with symptomatic coronary artery disease. Thromb Haemost 84(3), 364-368.
Marx PF, et al. (2000) Inactivation of active thrombin-activable fibrinolysis inhibitor takes place by a process that involves conformational instability rather than proteolytic cleavage. J Biol Chem 275(17), 12410-12415. doi: 10.1074/jbc.275.17.12410
Meijers JC, et al. (2000) Reduced activity of TAFI (thrombin-activatable fibrinolysis inhibitor) in acute promyelocytic leukaemia. Br J Haematol 108(3), 518-523. doi: 10.1046/j.1365-2141.2000.01890.x
Mao SS, et al. (1999) Characterization of plasmin-mediated activation of plasma procarboxypeptidase B. Modulation by glycosaminoglycans. J Biol Chem 274(49), 35046-35052. doi: 10.1074/jbc.274.49.35046
Boffa MB, et al. (1998) Plasma and recombinant thrombin-activable fibrinolysis inhibitor (TAFI) and activated TAFI compared with respect to glycosylation, thrombin/thrombomodulin-dependent activation, thermal stability, and enzymatic properties. J Biol Chem 273(4), 2127-2135. doi: 10.1074/jbc.273.4.2127
Bajzar L, et al. (1996) TAFI, or plasma procarboxypeptidase B, couples the coagulation and fibrinolytic cascades through the thrombin-thrombomodulin complex. J Biol Chem 271(28), 16603-16608.
Valnickova Z, et al. (1996) Activated human plasma carboxypeptidase B is retained in the blood by binding to alpha2-macroglobulin and pregnancy zone protein. J Biol Chem 271(22), 12937-12943. doi: 10.1074/jbc.271.22.12937
Eaton DL, et al. (1991) Isolation, molecular cloning, and partial characterization of a novel carboxypeptidase B from human plasma. J Biol Chem 266(32), 21833-21838.
Hendriks D, et al. (1989) Characterisation of a carboxypeptidase in human serum distinct from carboxypeptidase N. J Clin Chem Clin Biochem 27(5), 277-285.
Campbell W and Okada H (1989) An arginine specific carboxypeptidase generated in blood during coagulation or inflammation which is unrelated to carboxypeptidase N or its subunits. Biochem Biophys Res Commun 162(3), 933-939.
Fibrinogen to the top
Lowe G, et al. (2000) Blood rheology, cardiovascular risk factors, and cardiovascular disease: the West of Scotland Coronary Prevention Study. Thromb Haemost 84, 553-558.
Danesh J, et al. (1998) Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 279(18), 1477-82.
Danesh J, et al. (1998) Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies. JAMA 279(18), 1477-82.
Fibrinopeptide A to the top
Sonel A, et al. (2000) Prospective Study Correlating Fibrinopeptide A, Troponin I, Myoglobin, and Myosin Light Chain Levels With Early and Late Ischemic Events in Consecutive Patients Presenting to the Emergency Department With Chest Pain. Circulation 102(10), 1107-1113.
Rapold HJ, et al. (1989) Fibrin formation and platelet activation in patients with myocardial infarction and normal coronary arteries. Eur Heart J 10(4), 323-33.
Leptin to the top
Rahmouni K and Haynes WG (2004) Leptin and the cardiovascular system. Recent Prog Horm Res 59, 225-244.
El-Atat F, et al. (2003) Obesity and hypertension. Endocrinol Metab Clin North Am 32(4), 823-854.
Ogawa Y. et al. (1995) Molecular cloning of rat obese cDNA and augmented gene expression in genetically obese Zucker fatty (fa/fa) rats. J Clin Invest 96(3),1647-1652. doi: 10.1172/JCI118204
Zhang Y. et al. (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372(6505), 425-432.
Immunoglobulins to the top
Andreu-Ballester JC, et al. (2007) Secretory immunoglobulin A (sIgA) deficiency in serum of patients with GALTectomy. J Clin Immunol 123(3), 289–297. doi:10.1016/j.clim.2007.02.004
Eriksson S, et al. (2005) Negative Interference in Cardiac Troponin I Immunoassays by Circulating Troponin Autoantibodies. Clin Chem 51, 839-847. doi: 10.1373/clinchem.2004.040063.
Motoki K, et al. (2005) Enhanced Apoptosis and Tumor Regression Induced by a Direct Agonist Antibody toTumor Necrosis Factor-Related Apoptosis-Inducing Ligand Receptor 2. Clin Cancer Res 11(8), 3126-3135. doi: 10.1158/1078-0432.CCR-04-1867.
Urotensin II to the top
Toshiaki S, et al. (2007) Increased Human Urotensin II Levels Are Correlated With Carotid Atherosclerosis in Essential Hypertension. Am J Hypertens 20(2), 211-217.
Kwok Lo, et al. (2005) Urotensin II: Its Function in Health and Its Role in Disease. Cardiovasc Drugs Ther 19(1), 65-75. doi: 10.1007/s10557-005-6899-x
Onan D, et.al. (2004) UrotensinII: the old kid in town. TRENDS in Endocrinology and Metabolism 15(4), 175-182. doi:10.1016/j.tem.2004.03.007
Tzanidis A, et al. (2003) Direct actions of urotensin II on the heart. Implications for cardiac fibrosis and hypertrophy. Circ Res 93, 246-253. doi: 10.1161/01.RES.0000084382.64418.BC
Human Leukocyte Markers to the top
Shih T-C, et al. ( 2008) Aberrant activation of nuclear factor of activated T cell 2 in lamina propria mononuclear cells in ulcerative colitis. World J Gastroenterol 14(11), 1759–1767.
doi: 10.3748/wjg.14.1759
Büssing A, et al. (1999) Accidental cell death and generation of reactive oxygen intermediates in human lymphocytes induced by thionins from Viscum album L. Eur J Biochem 262(1), 79–87. doi: 10.1046/j.1432-1327.1999.00356.x
Hämäläinen MM, et al. (1999) Major Interference from Leukocytes in Reverse Transcription-PCR Identified as Neurotoxin Ribonuclease from Eosinophils: Detection of Residual Chronic Myelogenous Leukemia from Cell Lysates by Use of an Eosinophil-depleted Cell Preparation. Clin Chem45, 465-471.
Gangliosides to the top
Quintana FJ, et al. (2008) Antigen microarrays identify unique serum autoantibody signatures in clinical and pathologic subtypes of multiple sclerosis. Proc Natl Acad Sci105(48), 18889-18894. doi: 10.1073/pnas.0806310105.
Ewers H, et al. (2005) Single-particle tracking of murine polyoma virus-like particles on live cells and artificial membranes. Proc Natl Acad Sci U S A 102(42), 15110–15115.
doi: 10.1073/pnas.0504407102
Kolter T, et al. (2002) Combinatorial Ganglioside Biosynthesis. J Biol Chem 277(29), 25859-25862. doi: 10.1074/jbc.R200001200
Jeyakumar M, et al. (2002) Glycosphingolipid lysosomal storage diseases: therapy and pathogenesis. Neuropathol Appl Neurobiol 28(5), 343-57. doi: 10.1046/j.1365-2990.2002.00422.x
Beta-Galactosidase of E. coli to the top
Egami K, et al. (2003) Role of host angiotensin II type 1 receptor in tumor angiogenesis and growth. J Clin Invest 112(1), 67–75. doi: 10.1172/JCI200316645.
